International Journal of Cancer Management

Published by: Kowsar

The Accuracy of Sentinel Lymph Node Biopsy Following Neoadjuvant Chemotherapy in Clinically Node Positive Breast Cancer Patients: A Single Institution Experience

Hossein Yahyazadeh 1 , * , Maria Hashemian 1 , Mojtaba Rajabpour 1 , Saina Aminmozaffari 1 , Maryam Zaree 1 , Ahmad R Mafi 2 , Hossein Pourtavakoli 1 , Narges Sistany Allahabadi 1 and Marzieh Beheshti 1 , **
Authors Information
1 Clinical Cancer Research Center, Milad General Hospital, Tehran, IR Iran
2 Assistant Prof of Radiation Oncology, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Corresponding Authors:
Article information
  • International Journal of Cancer Management: December 31, 2018, 11 (12); e83946
  • Published Online: December 18, 2018
  • Article Type: Research Article
  • Received: September 5, 2018
  • Revised: December 3, 2018
  • Accepted: December 6, 2018
  • DOI: 10.5812/ijcm.83946

To Cite: Yahyazadeh H, Hashemian M, Rajabpour M, Aminmozaffari S, Zaree M, et al. The Accuracy of Sentinel Lymph Node Biopsy Following Neoadjuvant Chemotherapy in Clinically Node Positive Breast Cancer Patients: A Single Institution Experience, Int J Cancer Manag. 2018 ; 11(12):e83946. doi: 10.5812/ijcm.83946.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220(3):391-8. discussion 398-401. doi: 10.1097/00000658-199409000-00015. [PubMed: 8092905]. [PubMed Central: PMC1234400].
  • 2. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: Results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8(10):881-8. doi: 10.1016/S1470-2045(07)70278-4. [PubMed: 17851130].
  • 3. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998;16(8):2672-85. doi: 10.1200/JCO.1998.16.8.2672. [PubMed: 9704717].
  • 4. Xing Y, Foy M, Cox DD, Kuerer HM, Hunt KK, Cormier JN. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg. 2006;93(5):539-46. doi: 10.1002/bjs.5209. [PubMed: 16329089].
  • 5. Lee HD, Ahn SG, Lee SA, Lee HM, Jeong J. Prospective evaluation of the feasibility of sentinel lymph node biopsy in breast cancer patients with negative axillary conversion after neoadjuvant chemotherapy. Cancer Res Treat. 2015;47(1):26-33. doi: 10.4143/crt.2013.208. [PubMed: 25327493]. [PubMed Central: PMC4296849].
  • 6. Fu JF, Chen HL, Yang J, Yi CH, Zheng S. Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: A meta-analysis. PLoS One. 2014;9(9). e105316. doi: 10.1371/journal.pone.0105316. [PubMed: 25210779]. [PubMed Central: PMC4161347].
  • 7. Lee S, Kim EY, Kang SH, Kim SW, Kim SK, Kang KW, et al. Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients. Breast Cancer Res Treat. 2007;102(3):283-8. doi: 10.1007/s10549-006-9330-9. [PubMed: 17063280].
  • 8. Newman EA, Sabel MS, Nees AV, Schott A, Diehl KM, Cimmino VM, et al. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol. 2007;14(10):2946-52. doi: 10.1245/s10434-007-9403-y. [PubMed: 17514407].
  • 9. Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: The ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310(14):1455-61. doi: 10.1001/jama.2013.278932. [PubMed: 24101169]. [PubMed Central: PMC4075763].
  • 10. Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): A prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609-18. doi: 10.1016/S1470-2045(13)70166-9. [PubMed: 23683750].
  • 11. Caudle AS, Kuerer HM. Targeting and limiting surgery for patients with node-positive breast cancer. BMC Med. 2015;13:149. doi: 10.1186/s12916-015-0385-5. [PubMed: 26109042]. [PubMed Central: PMC4481081].
  • 12. Lee HK, Yang HK, Kim WH, Lee KU, Choe KJ, Kim JP. Influence of the number of lymph nodes examined on staging of gastric cancer. Br J Surg. 2001;88(10):1408-12. doi: 10.1046/j.0007-1323.2001.01875.x. [PubMed: 11578301].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments